At the end of January, the Academy released two statements regarding the accessibility and affordability of hearing care in the United States. These statements were driven by the considerable attention hearing care services and devices have received over the past 18 months in Washington, DC. Of particular interest is the outcome of a December meeting at the National Academies of Science, Engineering, and Medicine (NASEM), where the role of the audiology community in hearing care was readily apparent.
Topic(s): over-the-counter (OTC) hearing aids, audiology, Patient-Centered Care
DR. SUMIT DHAR: Hello Dr. Humes, thank you for agreeing to answer a few questions about your recent publication related to different modes of hearing aid delivery (Humes, 2017). I have many questions that probably are on the minds of readers as well.
Topic(s): audiology, over-the-counter (OTC) hearing aids
By now, audiologists are well aware that 2017 was a landmark year for audiology, or more specifically, for the industry that provides devices to manage our patients' hearing loss. Following the release of a series of reports calling for increased affordability and accessibility of hearing aids, including those from the Federal Trade Commission (FTC), the President's Council of Advisors on Science and Technology (PCAST), and the National Academies of Science, Engineering and Medicine (NASEM), President Trump signed the FDA Reauthorization Act of 2017 into law.
Topic(s): over-the-counter (OTC) hearing aids
In the classic movie, “The Wizard of Oz,” Dorothy realizes in order to reach the Emerald City, she must first travel through the dark and unfamiliar Enchanted Forest. Worried that they will be attacked, the Tinman predicts the forest will be filled mostly with “lions and tigers and bears.”
Topic(s): hearing aid, Food and Drug Administration (FDA), personal sound amplification products (PSAPs), over-the-counter (OTC) hearing aids, OTC Hearing Aid Act, Technology, Audiogram